You are here

  • Home
  • Archive
  • Volume 30, Issue Suppl 3
  • 1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial

Article metrics

Article menu

Download PDFPDF

Oral Plenary
Plenary I
IGCS20_1256
1 Avelumab in combination with and/or following chemotherapy vs chemotherapy in treatment-naive patients with ovarian cancer: biomarker analyses from the phase 3 JAVELIN Ovarian 100 trial
Free

 

Online download statistics by month:

Online download statistics by month: November 2020 to April 2024

AbstractFullPdf
Nov 202065010
Dec 20203008
Jan 20212204
Feb 20211806
Mar 20211902
Apr 20211203
May 20212008
Jun 2021104
Jul 2021104
Aug 2021004
Sep 2021005
Oct 202114019
Nov 202144017
Dec 20211204
Jan 20221401
Feb 20221202
Mar 2022801
Apr 20223006
May 202222013
Jun 202234012
Jul 20223203
Aug 20223704
Sep 202252010
Oct 20225406
Nov 20224802
Dec 20224805
Jan 20233603
Feb 20235007
Mar 20237909
Apr 20234004
May 20236204
Jun 20233003
Jul 20233408
Aug 202360011
Sep 20234203
Oct 20234400
Nov 20233207
Dec 20237507
Jan 20241801
Feb 20241602
Mar 20242103
Apr 2024603
Total12940238